For the Inventor, By the Inventor

Enter assignee name

Freiburg, Germany

Universitaetsklinikum Freiburg

USPTO Granted Patents = 40

CIPO Patents = 1

Forward Citations = 130

Loading Chart...

Loading Chart...

71 inventors (with patents filed for the assignee):

Maxim Zaitsev (12 out of 24 patents)

Juergen Hennig (7 out of 12 patents)

Roland Schuele (5 out of 6 patents)

4. Eric Metzger (4 out of 8 patents)

5. Gerrit Schultz (4 out of 4 patents)

6. Jürgen Hennig (4 out of 7 patents)

7. Daniel Gallichan (4 out of 4 patents)

8. Georg Bauer (3 out of 6 patents)

9. Peter Ullmann (3 out of 7 patents)

10. Guobin Li (2 out of 6 patents)

11. Thorsten Steinberg (2 out of 5 patents)

12. Pascal Tomakidi (2 out of 4 patents)

13. Marco Idzko (2 out of 2 patents)

14. Stephan Sorichter (2 out of 2 patents)

15. Kuan Jin Lee (2 out of 2 patents)

Core Competencies:

CD40L/Mac-1 Interaction

Type 2 Diabetes

Magnetic Resonance Imaging

Catalase Inhibitors

Uridine Analogues

Autoimmune Diseases

Androgen Receptor Control

Antimicrobial Polymers

Tumor Apoptosis

Monoclonal Antibodies

NMR Tomography

Hyaluronic Acid Fragments

40 patents: Sort by Forward Citations

1. 10994010 - Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis (2021-05-04),

2. 10299467 - Animal model for type 2 diabetes and obesity (2019-05-28),

3. 10281548 - Method of magnetic resonance with excitation by a prewinding pulse (2019-05-07),

4. 9801832 - Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction (2017-10-31),

5. 9795625 - Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis (2017-10-24),

6. 9695480 - Method for the diagnosis of myeloid neoplasias and solid tumors (2017-07-04),

7. 9631235 - Mitochondrial nucleic acid as a marker for autoimmune and autoinflammatory diseases (2017-04-25),

8. 9494670 - Method for improving robustness of 3D magnetic resonance imaging to involuntary motion (2016-11-15),

9. 9476957 - Method and apparatus for accelerating magnetic resonance imaging (2016-10-25),

10. 9377517 - Method of dynamically compensating for magnetic field heterogeneity in magnetic resonance imaging (2016-06-28),

11. 9370499 - Androgen receptor-dependent gene expression control (2016-06-21),

12. 9366679 - Method for diagnosis of pulmonary involvement in systemic sclerosis (2016-06-14),

13. 9333216 - Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis (2016-05-10),

14. 9332755 - Covalently attached antimicrobial polymers (2016-05-10),

15. 9255157 - [object Object] (2016-02-09),

Universitätsklinikum Freiburg is a leading medical institution and academic teaching hospital in Freiburg, Germany. With a rich history spanning over 250 years, it offers a wide range of medical services, research opportunities, and education programs. The clinic is affiliated with the University of Freiburg and collaborates with various national and international partners. Committed to excellence in patient care, research, and education, Universitätsklinikum Freiburg strives to advance medical knowledge and improve the well-being of individuals and communities.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

40 Patents

#9 in Freiburg

#1,301 in Germany

#16,572 in the World

Freiburg, Germany

Universitaetsklinikum Freiburg

Forward Citations = 130

71 inventors:

Maxim Zaitsev (12 out of 24 patents)

Juergen Hennig (7 out of 12 patents)

Roland Schuele (5 out of 6 patents)

4. Eric Metzger (4 out of 8 patents)

5. Gerrit Schultz (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…